三星医疗(601567.SH)：第三季度净利润同比下降55.22%

Core Viewpoint - Samsung Medical (601567.SH) reported a decline in both revenue and net profit for Q3 2025, indicating potential challenges in its financial performance [1] Financial Performance - The company's operating revenue for Q3 2025 was 3.108 billion yuan, representing a year-on-year decrease of 9.56% [1] - The net profit attributable to shareholders was 298 million yuan, down 55.22% year-on-year [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 144 million yuan, reflecting a significant decline of 78.54% year-on-year [1]